Market Research Blog – Page 1189 – New Product Development

Smart Insulin Pens Market Set to Reach USD 8,750.7 Million by 2033, Growing at 8.3% CAGR

The smart insulin pens market is projected to experience significant growth, with an estimated valuation of USD 3,927.3 million in 2023. By 2033, the market is expected to reach USD 8,750.7 million, reflecting a robust compound annual growth rate (CAGR) of 8.3% during the forecast period.

The rising prevalence of diabetes worldwide and the increasing demand for effective diabetes management solutions are key factors driving the growth of the smart insulin pens market. These innovative devices not only enhance insulin delivery but also offer features such as dose tracking, reminders, and data sharing with healthcare providers, thereby empowering patients to manage their condition more effectively.

Smart insulin pens are revolutionizing diabetes management by providing users with advanced features such as precise dosing, real-time tracking, and integration with digital health platforms. The increasing adoption of these innovative devices is driven by their ability to enhance insulin administration accuracy and improve overall diabetes care.

The increasing adoption of smart insulin pens is attributed to their advanced features, such as real-time glucose monitoring, precise dosing, and enhanced patient management capabilities. As diabetes management continues to evolve, smart insulin pens are becoming a critical tool for improving patient outcomes and convenience.

Smart insulin pens, designed to enhance the management of diabetes through advanced technology and real-time monitoring, are becoming increasingly essential in diabetes care. Their ability to provide accurate dosage tracking, integration with digital health tools, and improved patient convenience are key factors driving their adoption.

Manufacturers are thus capitalizing on these trends to launch fresh and inventive product lines, allowing them to gain a firm foothold in the market. Medtronic, for example, will debut its InPenTM smart insulin device with real-time GuardianTM Connect CGM Data in November 2020, making it the first smart insulin pen for diabetics who require many daily injections. BioCorp and Roche Diabetes Care just launched the Mallya smart insulin pen device in France in April 2021.

Key Takeaways from FMI’s Global Smart Insulin Pens Industry Report

Bluetooth-enabled Smart Insulin Pens will account for more than half of the revenue share by 2031.
According to indications, type 2 diabetes therapy will account for the majority of smart insulin pen deployment.
Smart Insulin Pens were primarily distributed through retail pharmacies, with e-commerce sales fast increasing.
The United States will see credible growth as the approval rate for new diabetes treatment devices rises.
Growing acceptance of needle-free insulin injections in the United Kingdom
In the long run, Germany and France will see increasing collaboration between key manufacturers.
A high concentration of regional manufacturers will drive growth in India and China.

Smart Insulin Pens Market – Key questions answered in the report

What trends are in store for the Smart Insulin Pens Market growth?

According to FMI, the Global Smart Insulin Pens Industry is expected to reach multi-billion dollar valuations in both the short and long run, owing to an increase in the global diabetes population pool and the resulting increase in hospital workload. Bluetooth-enabled Smart Insulin Pens are predicted to stay in high demand.

Which is the most promising Smart Insulin Pens Market?

According to FMI’s estimate, demand for Smart Insulin Pens is projected to continue high in the US market, owing to the government’s ongoing efforts to eradicate the diabetes epidemic through major advertising campaigns. Furthermore, with the presence of multiple regional-level producers, India and China are likely to emerge as the main markets in the Asia-Pacific region.

Smart Insulin Pens Market Competitive Landscape

significant insulin pen manufacturers are efficiently using significant expansion tactics, such as new product releases and R&D, collaboration with current manufacturers, and outright/partial purchase of important market participants. The incorporation of virtual technological breakthroughs to improve diabetes care is being prioritized.

Novo Nordisk and the University of Toronto signed a CAD 40 million investment agreement in February 2021 to establish the Novo Nordisk Network for Healthy Populations. This network will concentrate on novel methods of diabetes management and chronic disease prevention. This will most likely aid in the creation of Smart Insulin Pens.

Companies are also focusing on providing advanced software platforms, such as Digital Medics’ DiabetesPlus DataSync Software. This platform enables users to download insulin and glucose data directly from the device. Key features include downloading insulin data from the insulin pen, glucose levels from the glucose meter, and synchronization of data on the Cloud for use with mobile devices.

Smart Insulin Pens Market Key Players

Digital Medics Pty Ltd.
Emperra GmbH e-Health Technologies
Companion Medical Inc.
Sanofi Aventis LLC
Novo Nordisk A/S
Eli Lily and Company
Companion Medical
Diabnext
Jiangsu Delfu Medical Device Co. Ltd.
DIAMESCO Co Ltd.
Patients Pending Ltd (Bigfoot Biomedical Inc.)
BERLIN-CHEMIE

A Old Full Report Analysis Click Here

Smart Insulin Pens Market – Key Segments Covered

Indication

Diabetes Type I
Diabetes Type II

Connectivity

Bluetooth Connected
USB Connected

Distribution Channel

Clinics & Ambulatory Surgical Centers
E-Commerce
Retail Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Middle East Veterinary Vaccine Market Expected to Reach USD 973.8 Million by 2033, Growing at 4% CAGR

The Middle East veterinary vaccine industry is projected to experience steady growth, with an anticipated expansion at a compound annual growth rate (CAGR) of 4% through 2033. The demand outlook for veterinary vaccines in the region is valued at USD 627.1 million in 2023, and by 2033, sales are expected to surpass USD 973.8 million.

This growth in the veterinary vaccine market is driven by several factors, including the increasing awareness of animal health, rising livestock populations, and the growing demand for quality meat and dairy products. Additionally, heightened focus on zoonotic diseases and the importance of vaccination in preventing outbreaks are further fueling market demand.

This anticipated growth reflects a rising demand for veterinary vaccines across the region, driven by several key factors. Increasing awareness of animal health and welfare, coupled with advancements in vaccine technology, is propelling the need for effective vaccination solutions. Veterinary vaccines play a crucial role in preventing and controlling diseases among livestock and companion animals, thereby supporting both animal health and public safety.

This growth is driven by increasing awareness of animal health, advancements in veterinary medicine, and a rising demand for effective vaccines to combat animal diseases across the region. The Middle East is experiencing an upsurge in investment in veterinary healthcare infrastructure, which is further fueling the demand for innovative vaccine solutions.

The rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This will fuel the demand for effective vaccination of livestock, especially in major animal farming and meat-producing nations in the region with a diversified herd such as Sudan, Turkey, Egypt, and KSA.

Rising per capita disposable income levels are largely contributing to the demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments.

The key players in the veterinary vaccine industry are focusing on finding innovative products to control zoonotic infection rates. Along with this, various advancements in biotechnology are expected to create a favorable platform for the development of various veterinary vaccines in developing markets such as UAE, KSA, Turkey, and Jordan. These techniques include next-generation sequencing, synthetic biology, and systems biology, among others.

Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten the time-to-market for upcoming veterinary vaccines.

Key players are working on innovative products, conducting acquisitions, mergers, and agreements with other companies to improve their market presence and tap into less competitive emerging markets.

For instance, In September 2018, Boehringer Ingelheim announced that they would be donating 75,000 doses of rabies vaccines to the Global Alliance for Rabies Control, as an effort to recognize World Rabies Day on September 28^th.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level and help companies to sustain the increasing competitive pressure.

Key Takeaways from the Middle East Veterinary Vaccines Industry Study

The Middle East veterinary vaccine market is expected to grow consistently, reaching a projected value of US$ 973.8 million by 2033.
This growth is driven by a CAGR of 4%, indicating a steady increase in demand for veterinary vaccines.
The current market size stands at US$ 627.1 million in 2023, highlighting the existing base for further expansion.

“Increased demand for processed meat products around the world will drive the demand for veterinary vaccines market in the Middle East,” says the FMI Analyst.

The key market players of the Middle East veterinary vaccines market include :

JOVA, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva and Boehringer Ingelheim.

A Old Full Report Analysis Click Here

Middle East Veterinary Vaccines Industry, by Category

By Vaccine:

Attenuated Live Vaccines
Inactivated Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Others

By Animal:

Companion Animals
- Canine
- Avian
- Feline
Livestock Animals
- Aquatic
- Bovine
- Porcine
- Small Ruminant
- Poultry
Equine

By Disease Indication:

Foot and Mouth Disease
Newcastle Disease
PPRS
Canine Parvovirus
Brucellosis
Avian Influenza
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Orthopedic Imaging Equipment Market to Reach USD 14.6 Billion by 2031 at a 4.0% of CAGR

The global orthopedic imaging equipment market, valued at USD 9.8 billion in 2021, is projected to experience significant growth, reaching an estimated USD 14.6 billion by 2031. This expansion reflects a growing demand for advanced diagnostic imaging solutions driven by the increasing number of accidents, sports injuries, and fractures.

The growing frequency of orthopedic conditions due to an increase in physical activities and accidents is fueling demand for advanced diagnostic imaging technologies. Orthopedic imaging plays a crucial role in accurately diagnosing bone and joint issues, enabling timely and effective treatment. As sports participation rises and road traffic accidents remain prevalent, the need for sophisticated imaging solutions is becoming more pronounced.

The surge in market demand is closely linked to the escalating need for advanced diagnostic imaging technologies in orthopedic care. As the frequency of such injuries continues to rise, so does the necessity for accurate and efficient imaging solutions that aid in precise diagnosis and treatment planning.

Rising prevalence of Orthopaedic diseases and bone injuries, technological advancement in Orthopaedic imaging equipment devices, and rise in research and development activities by key manufacturers are factors driving the Orthopaedic imaging equipment market.

Numerous medical imaging modalities are currently enabling three-dimensional (3D) visualization with accuracy, and rapid diagnoses. Advancements in 3D imaging have led to development in computer-assisted detection (CAD) and image analysis applications. This is expected to boost the market for modality, primarily in tomographic imaging techniques.

Moreover, surgeons are using 3D imaging to plan surgeries, which has led to increased application of these systems. This is expected to increase the utilization of imaging equipment, especially across the U.S. and the U.K.

Consequently, these devices are also gaining high traction in Asia such as China and India due to growing demand for better health care infrastructure. Improving healthcare infrastructure and technological developments in these countries will increase the demand for 3D medical imaging equipment.

Key Takeaways from Orthopaedic Imaging Equipment Study

In terms of product type, the X-ray systems is expected to account for 28.0%, expanding at a CAGR of 3.3% during the forecasted period.
By indication, the acute injuries segment will contribute over 56.6% of sales in the global Orthopaedic imaging equipment market.
Hospitals and radiology centers will, collectively, account for 68.2% of the market share in 2021.
With the advancements in technologies as well as the increasing geriatric population, North America held the largest share of over 30.5% in 2021.
India and China are expected to lead the growth of South and East Asia in the global Orthopaedic imaging equipment market.

Who is winning?

The key market players covered by FMI include General Electric Healthcare Limited, Siemens AG, Esaote SPA, Hitachi Ltd, Koninklijke Philips N.V, PLANMED OY, EOS imaging, Canon Medical Systems Corporation, Carestream Health and Neusoft Corporation.

Some of the leading manufacturers of the Orthopaedic imaging equipment market are focusing on the development of advanced and cost-effective products establishing distribution agreements, collaborations and partnerships strategies for global expansion objectives, thereby, enhancing their market presence.

In September 2021, GE Healthcare acquired BK Medical for $1.45Bn to expand its $3bn ultrasound business from diagnostics to surgical and therapeutic interventions.
In April 2016, Hitachi Ltd Company integrated Hitachi Medical Corporation and Hitachi Aloka medical into Hitachi Ltd to strengthen its manufacturing operations and to develop low-cost medical devices.

A Old Full Report Analysis Click Here

Orthopedic Imaging Equipment Industry by Category

By Product:

X-Ray Systems
CT-Scanner
MRI Systems
EOS Imaging Systems
Ultrasound
Nuclear Imaging Systems

By Indication:

Acute injuries
- Sports injuries
- Trauma cases
Chronic Disorders
- Osteoarthritis
- Osteoporosis
- Prolapsed Disc
- Degenerative joint diseases
Others

By End-User:

Hospitals
Radiology Centers
Emergency Care Facility
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Burglar Alarm Systems Market 2022 Size, Growth Analysis Report, Forecast to 2032

The global burglar alarm systems market was estimated at US$ 5.5 Billion in 2021 and is projected to procure US$ 5.9 Billion by 2022. The market is anticipated to garner US$ 11.8 Billion by 2032 while recording a CAGR of 7.2% during the forecast period from 2022 to 2032. Expansion of the market can be attributed to the increasing utility in residential and commercial buildings and the adoption of advanced technologies like AI & Big data to enhance security services across various developing countries.

Moreover, wireless burglar alarms are another salient factor augmenting the industry in the assessment period. The growing usage of these Burglar Alarm Systems in huge buildings where it is very difficult and inefficient to provide security by physical mode, these system increases sets the alarms in case of any movement and alerts the concerned person or authority. Thereby, with the soaring infrastructural growth, the demand for these alarming systems is increasing vigorously.

However, the false alarms triggered by the inaccuracy of systems to catch sounds have created discontent in the minds of people which is likely to impede the growth of the global burglary alarm systems in the forthcoming period.

Key Takeaways from the Market Study

Burglar alarm systems for residential applications to account for 55% revenue share
Wired alarm systems accounted for over 3/5th market revenue as of 2021
The North American market is expected to secure US$ 6.8 Billion while expanding at a CAGR of 7%
Asia Pacific to experience noteworthy growth, anticipated to reach almost US$ 2 Billion by the end of the 2022–2032 forecast period
Global burglar alarm systems market value to experience 2x growth from 2022–2032

Competitive Landscape

Key players in the global Burglar Alarm Systems market include ADT, ASSA ABLOY, Banham, Hangzhou Hikvision Digital Technology Co., Ltd., Honeywell International, Inc, Inovonics Wireless Corporation, Johnson Controls, Securitas AB, Siemens, Risco Group, Napco Security Technologies, Inc. Some of the recent key developments among the players are:

In March 2022, ASSA ABLOY, the global leader in access solutions, will be exhibiting its latest innovations when the company debuts its exciting new booth at ISC West. With emerging security issues due to the ongoing health, economic, and social crises, ASSA ABLOY’s primary focus will be on helping attendees identify new opportunities for improving health, safety, and access at their facilities.
In Sept 2022, Honeywell International, Inc., announced the release of Pro-Watch® Integrated Security Suite, a software platform designed to help protect people and property, optimize productivity and ensure compliance with industry regulations. The platform provides complete visibility of all connected systems and the scalability of the software makes it easy to grow with the changing needs of a business.

More Valuable Insights Available

FMI, in its new offering, presents an unbiased analysis of the global Burglar Alarm Systems market, presenting historical market data (2017–2021) and forecast statistics for the period of 2022–2032.

The study reveals essential insights based on type (wireless and wired), component (hardware, software and services) and application (commercial & industrial and residential) & across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Key Segments Covered In The Burglar Alarm Systems Industry Survey

Burglar Alarm Systems by Type:

Wireless Burglar Alarm Systems
Wired Burglar Alarm Systems

Burglar Alarm Systems Market by Component:

Burglar Alarm Systems Hardware
Burglar Alarm Systems Software
Burglar Alarm Systems Services

Burglar Alarm Systems Market by Application:

Burglar Alarm Systems for Commercial & Industrial Applications
Burglar Alarm Systems for Residential Applications

Burglar Alarm Systems Market by Region:

North America Burglar Alarm Systems Market
Latin America Burglar Alarm Systems Market
Europe Burglar Alarm Systems Market
Asia Pacific Burglar Alarm Systems Market
Middle East & Africa Burglar Alarm Systems Market

Get a Sample Copy of Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-14939

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Russia Viscosupplementation Market Is Expected to Top USD 84.86 Million by 2032, Driven by a 6.2% CAGR

Global Russia Viscosupplementation Industry — Russia Viscosupplementation Market

A recent report by Future Market Insights (FMI) predicts the Russia Viscosupplementation Market will exceed a valuation of USD 84.86 million by 2032, reflecting a steady CAGR of 6.2% through the forecast period.

Key Findings from the “Viscosupplementation Market: Russia Industry Analysis and Opportunity Assessment, 2016-2026” Report:

Market Dominated by 3-Injection Treatments: In 2016, nearly 70% of Russia’s viscosupplementation market revenue came from 3-injection treatment options.
Strong Growth Trajectory: The report estimates Russia’s viscosupplementation market generated over USD 19 million in 2016.
CAGR of 5.8% Projected: FMI predicts continued growth, with revenues expected to reach US$34 million by 2026.

With higher demand for three-injection viscosupplementation, Russia’s healthcare industry leaders will continue to extend production of three-injection viscosupplementation products as opposed to single-injection and five-injection viscosupplementation products.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-ru-2897

Russia’s healthcare infrastructure will continue witnessing a significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation as an ideal medical procedure for injecting lubricating fluid in bone joints during surgeries. An in-depth analysis of Russia Viscosupplementation Industry conducted by Future Market Insights, projects that demand for three-injection viscosupplementation will gain traction over the next decade.

The report also establishes projections regarding the end-use of viscosupplementation in Russia. Hospitals across the country will account for just above RUB 1.24 billion (US$ 21 million) revenues by the end of projection period. Within this, the demand for viscosupplementation will remain considerably higher in hospitals with capacity of more than 500 beds. End-use of viscosupplementation in Russia’s ambulatory surgical centres (ASCs) will remain nascent, while revenues accounted by orthopaedic clinics are expected to surpass RUB 595 million (US$ 10 million) through 2026.

Top Players in Russia Viscosupplementation Market

The top three established players in Russia’s Viscosupplementation market include Hyaltech, Croma-Pharma GmbH and TRB Chemedica. The market is fragmented with small players holding substantial market share. While Hyaltech, Croma-Pharma GmbH and TRB Chemedica collectively dominate with more than half of the country’s viscosupplementation revenues.

International players such as Sanofi, Ferring Pharmaceuticals and Fidia Farmaceutici spa have low share as compared to the other players, Anika Therapeutics has recently launched their viscosupplementation product in Russia Viscosupplementation Industry

Ask For Customization
https://www.futuremarketinsights.com/customization-available/rep-ru-2897

The Russia Viscosupplementation Market is divided into two segments based on product type and end use:

By Product Type

Single Injection Viscosupplementation
Three Injection Viscosupplementation
Five Injection Viscosupplementation

By End Use

Hospitals
- 500+ Bedded
- 250-500 Bedded
- Less Than 250 Bedded
Ambulatory Surgical Centres
Orthopaedic Clinics

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Global Branded Generics Market Poised for Remarkable Growth, Set to Reach USD 747.2 Million by 2033 at a 8.6% of CAGR

The global branded generics market is poised for substantial expansion, with its valuation expected to surge from approximately USD 327.8 million in 2023 to an impressive USD 747.2 million by 2033. This significant growth, translating to an 8.6% compound annual growth rate (CAGR), highlights a dynamic upward trend driven by evolving industry conditions and key market drivers.

The accelerating demand for branded generics is predominantly fueled by several pivotal factors. A major influence is the expiration of patents that previously granted exclusive market rights to original drug manufacturers. As these patents lapse, branded generics emerge as viable alternatives, offering high-quality yet more affordable options to consumers. This shift is further supported by increasing government initiatives aimed at raising public awareness and improving access to cost-effective pharmaceutical solutions.

The market’s expansion is also driven by considerable advancements in research and development. Ongoing innovation and increased investment in R&D are essential for enhancing healthcare infrastructure, especially in emerging economies. These technological advancements are creating new opportunities and accelerating the demand for branded generics. Future market growth is anticipated to be supported by sustained R&D efforts and continued technological breakthroughs.

Regionally, North America continues to hold a significant share of the branded generics market, thanks to its advanced healthcare facilities and well-established infrastructure. However, the Asia Pacific region is expected to witness the most rapid growth. This anticipated surge is attributed to the rising demand for affordable pharmaceutical products and increased government support aimed at enhancing healthcare accessibility.

As the branded generics market continues to evolve, stakeholders and industry players are poised to benefit from this robust growth trajectory, driven by a combination of patent expirations, technological advancements, and regional shifts in demand.

Key regional projections include:

China Projected to expand at a CAGR of 10.4% from 2023 to 2033.
India Anticipated to grow at an impressive CAGR of 11.9% during the forecast period.
Australia Expected to expand at a CAGR of 7.5%.
United States Forecasted to increase its market share by 16.8% between 2023 and 2033.
Germany Expected to hold a market share of 2.9%.
Japan Projected to capture a 4.4% market share.
United Kingdom Likely to register a 9.5% CAGR.

Market Segmentation and Key Takeaways:

The branded generics market is segmented by therapeutic application, drug class, formulation type, and distribution channel:

Anti-Hypertensive Drugs: Leading the drug class category with a 27.5% revenue share in 2023.
Cardiovascular Diseases: Expected to dominate the therapeutic application category, with a projected market share of 17.95% by 2033.
Retail Pharmacy: Accounted for a substantial 43.7% of the distribution channel segment in 2023.

Competitive Landscape and Recent Developments:

The branded generics market is highly competitive, with numerous manufacturers entering the space. Notable recent developments include:

Acquisition: In July 2021, Lupin acquired Southern Cross Pharma Pty Ltd, enhancing its presence in the branded generics market.
Product Launch: Dr. Reddy’s Laboratories introduced Invista in India, a branded generic version of Sprycel, in April 2020. Teva Pharmaceuticals and Hikma Pharmaceuticals released a generic version of Tracleer in the U.S. in June 2019.

Elevated Demand for Branded Generics: Our Full Report Offers a Thorough Analysis of Trends and Insights!

Key Players:

Prominent manufacturers in the branded generics market include:

Teva Pharmaceuticals Industries Ltd.
Abbott Laboratories
Novartis
Mylan
Pfizer

Branded Generics Market by Category Therapeutic Application:

Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Dermatology Diseases
Analgesics and Anti-inflammatory
Others

Drug Class:

Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Others

Formulation Type:

Oral
Parenteral
Topical
Others

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Bone Densitometer Devices Market Expected to Reach USD 525 Million by 2033, Growing at 4.2% CAGR

The global bone densitometer devices market is projected to exceed USD 347.7 million in 2023, with an anticipated growth trajectory leading to a valuation of USD 525.0 million by 2033. This expansion represents a compound annual growth rate (CAGR) of 4.2% from 2023 to 2033.

Bone densitometer devices are essential for conducting non-invasive procedures to assess bone density and measure bone strength. These devices play a crucial role in diagnosing bone-related diseases and analyzing the risk of developing such conditions, making them vital tools in preventative healthcare.

Bone densitometer devices play a crucial role in healthcare by offering a non-invasive solution to measure bone density and assess bone strength. These devices are pivotal for the early diagnosis of bone-related diseases such as osteoporosis, as well as for evaluating patients’ risk of developing such conditions.

Bone densitometer devices play a crucial role in diagnosing and managing bone-related diseases by performing non-invasive procedures to assess bone density and strength. These devices are essential for detecting conditions such as osteoporosis and for evaluating the risk of fractures, thereby aiding in early diagnosis and effective management of bone health.

As awareness of bone health issues rises, so does the demand for accurate and reliable diagnostic tools. Bone densitometers are increasingly used in both clinical and research settings to monitor bone health, especially in populations at higher risk for bone density loss.

Bone densitometers also analyze the risk of developing bone disorders. One of the major market drivers for bone densitometer devices is the rising incidences of knee osteoarthritis. With over 203 knee osteoarthritis cases for every 10,000 persons, 20 years of age and above, bone densitometer devices are expected to be in high demand in the upcoming years.

Moreover, a surge in favorable reimbursement policies by Medicare will likely spur the demand for bone densitometer devices, particularly in countries like India and the U.S. Medicare provides private health insurance plans for the treatment of osteoporosis, which in turn accounts for the increasing expansion of the bone densitometer devices market. Also, many manufacturers are keen on releasing innovative products with novel offerings like low dosage and patented narrow-fan beam technology.

This factor coupled with the rising need for excellent precision and accuracy, high-definition image quality, and faster scans for multiple clinical applications will foster an atmosphere of growth for the target over the projected period.

“Growing bone health awareness, more widespread knowledge about osteoporosis along with initiatives from NGOs and government organizations will likely drive the market growth for the bone densitometer devices over the forecast period,” says an FMI analyst.

Bone Densitometer Devices Market Key Takeaways:

Heightened demand for precise, speedy, and high-quality diagnosis to strengthen the market prospects.
The high cost of the target product and limitations of the DXA technology of bone densitometer devices will impede the market growth.
The U.S. will dominate the global market space with a CAGR of 4.9%.
The market in Germany will be driven by increasing bone disorder awareness programs.
Axial bone densitometer segment will grow at a CAGR of 4.2%
In terms of technology, Dual Energy X-ray absorptiometry will hold about 3/5th of total revenue.

Bone Densitometer Devices Market Competitive Landscape

GE Healthcare, Hologic, Inc., OSI Systems, Inc., Diagnostic Medical Systems Group, Swissray Global Healthcare Holding, Ltd., BeamMed, Ltd., Echolight S.P.A, Scanflex Healthcare AB, Medonica Co., Ltd., XinGaoYi Co., Ltd., Anjue Medical Equipment, Trivitron Healthcare, Eurotec Systems S.r.l, AMPall Co., Ltd., L’acn L’accessorio Nucleare S.R.L, Shenzhen XRAY Electric Co., Ltd., YOZMA BMTech Co., Ltd., Nanoomtech Co., Ltd., Osteosys Corporation, FURUNO Electric Co., Ltd ., and others are some of the major players in the bone densitometer devices market profiled in the full version of the report.

Leading market players are concentrating on improving their product features to expand their business and enter new markets. Strategies like mergers, acquisitions, and distribution agreements are also employed by these enterprises to strengthen their position in the bone densitometer devices market.

A Full Report – Overview

Bone Densitometer Devices Market by Category

By Product:

Peripheral Bone Densitometer
Axial Bone Densitometer

By Technology:

Dual Energy X-ray absorptiometry (DXA)
Peripheral Dual Energy X-Ray
Absorptiometry (pDXA)
Quantitative Ultrasound (QUS)
Others

By End-User:

Hospitals
Orthopedic Clinics
Diagnostic Centers

About Future Market Insights (FMI)

Contact Us:

Portable Ultrasound Bladder Scanner Market Projected to Reach USD 188.8 Million by 2034, Growing at 3.1% CAGR

The global portable ultrasound bladder scanner market is forecasted to exhibit steady year-on-year growth, with an anticipated market value of USD 139.9 million in 2024. According to recent projections, global sales of portable ultrasound bladder scanners are expected to rise at a compound annual growth rate (CAGR) of 3.1%, reaching a total valuation of USD 188.8 million by 2034.

Among the notable trends in the market, 3D portable ultrasound bladder scanners are predicted to remain highly sought-after products during the forecast period. This segment is set to progress at a robust 3.3% CAGR between 2024 and 2034, driven by their advanced imaging capabilities and increased demand for precise bladder assessment in clinical settings.

3D portable ultrasound bladder scanners are anticipated to drive demand during this period, with this segment growing at a slightly higher CAGR of 3.3% from 2024 to 2034. These scanners offer enhanced diagnostic capabilities, making them a popular choice among healthcare providers.

The demand for portable ultrasound bladder scanners is being driven by their increasing applications in both clinical and emergency settings, where quick and accurate bladder assessments are crucial. This steady growth reflects the broader trend towards portable diagnostic solutions in healthcare.

Notably, 3D portable ultrasound bladder scanners are anticipated to be a major contributor to market expansion. This segment is expected to grow at a robust 3.3% CAGR from 2024 to 2034, underscoring the rising preference for advanced imaging technologies that provide more detailed and accurate results.

Manufacturers of portable ultrasound bladder scanners are focussing on the development of novel and cost-effective bladder scanner devices and are also establishing distribution agreements to increase geographic reach, especially in the Asia Pacific region. This comprehensive report on the global portable ultrasound bladder scanner market studies seven key regions across the globe and includes a market overview along with market forecast, drivers, restraints, trends and opportunities.

The pricing analysis presented in the report includes the weighted average pricing of a single portable ultrasound bladder scanner. A demand-supply gap analysis has been carried out involving both marketplace discussions and desk research to determine pricing premiums. A country-wise analysis scenario includes price projections across various countries. Manufacturers and suppliers play a pivotal role, particularly in the global portable ultrasound bladder scanner market and taking this into consideration, the value chain of the portable ultrasound bladder scanner market has also been analysed in this report.

Our expert analysts have utilised PEST (Political, Economic, Social and Technological) analysis while drafting this report. Besides, a detailed global epidemiology of urological disorders has been included in the report to provide a clear picture of the market scenario across the globe.

In 2020, the items received CE certification and FDA approval from the United States. The least invasive, successful alternative to conventional endoscopic stricture treatments for male anterior urethral strictures is Optilume®.

Moreover, Laborie Medical Technologies Corp. (Laborie) purchased Pelvalon, Inc. in October 2021. Pelvalon produces cutting-edge technologies like the EclipseTM System, a non-surgical, patient-controlled device for women with faecal incontinence (FI).

The portable ultrasonography bladder scanning devices have undergone tremendous progress, which offers additional therapeutic recommendations.

Unique report structure

Primarily, the report on the global portable ultrasound bladder scanner market presents an overview of the entire market for portable ultrasound bladder scanner devices across the globe. The overview is followed by a market taxonomy, where the global portable ultrasound bladder scanner market is segmented based on product, end user, and region. Future Market Insights has leveraged a bottom-up approach to assess market numbers for each product category and a top-down approach to counter-validate the reached numbers.

Macroeconomic indicators such as the healthcare industry outlook, healthcare spending, and prevalence of cancer have been considered to arrive at the indicated market numbers. The analyst team has also provided key strategic recommendations for both existing and new players in the global portable ultrasound bladder scanner market to emerge sustainably profitable. The report further covers the competitive landscape that provides a dashboard view of companies that manufacture and provide services in the global portable ultrasound bladder scanner market.

The report highlights company profiles of some of the key players and a strategic overview of mergers and acquisitions along with their expansion plans across different regions. The subsequent sections analyse the global portable ultrasound bladder scanner market based on product type, end user and region, and present a comprehensive forecast for the period 2016–2026.

A Full Report – Overview

The Portable Ultrasound Bladder Scanner Market is segmented as follows:

By Product

2D Portable Ultrasound Bladder Scanner
3D Portable Ultrasound Bladder Scanner

By End User

Hospitals
Diagnostic Centres
Clinics
Ambulatory Surgical Centres

By Region

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Stock Trading App Market Expected to Reach US$ 1,10,624.4 Million by 2033, Driven by 21.1% CAGR

The stock trading app market is anticipated to be worth US$ 13.6 billion in 2022 and US$ 89.8 billion by 2032. So until 2032, the market is anticipated to grow by 20.8%.

The largest portion of precast concrete demand by-products is for stock trading app platforms, and demand is projected to increase at the quickest rate through 2032.

One of the newest trends in the market is chatbots powered by artificial intelligence, which are becoming more and more common with electronic trading platforms. Chatbots are used by traders for a number of purposes, such as answering common FAQs, offering real-time estimations, reporting their accounts, getting account notifications, and assessing market conditions. Artificial intelligence-driven market insight from stock trading apps promotes the use of trading platforms.

The future of these trading platforms is anticipated to undergo significant change due to artificial intelligence (AI). By using robo-advisors, businesses are integrating artificial intelligence into their trading systems. The market for solutions is anticipated to grow as brokers want more specialized trading platforms.

Solutions and services are segmented on the market based on their constituent parts. Over the course of the forecast, online trading platforms are anticipated to overtake the solutions segment in market share. Due to the rising need for such solutions, more and more brokers and trading companies are utilizing bespoke trading platforms. Within the brokerage industry, there will be a demand for cloud-based stock trading app markets.

Government regulations, international regulatory organizations, self-regulatory organizations, and various exchanges, however, aggressively regulate enterprises that provide online trading software.

Vendors must follow regulations and compliance procedures. In order to perform customer operations, vendors must also abide by a number of rules imposed by major regulators. As a result, if the vendor is unable to follow the guideline, they may be punished. Developing countries may obstruct the expansion of

due to a lack of knowledge about solutions, and the stock trading app market for online trading platforms in the near future.

Global demand for stock trading apps is surging;

With the help of online platform solutions for trading, banks, traders, and individual brokers can evaluate opportunities on the financial markets and eliminate risk factors.

It is predicted that demand for the stock trading app market will increase due to the increased demand for customized trading platforms from end-users, such as government and non-profit banks.

Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14931

About Future Market Insights (FMI)

Contact Us:

Global Cancer Supportive Care Products Market, Reaching USD 32 Billion by 2030

The Global Cancer Supportive Care Products Industry is poised for significant growth, with a projected valuation of USD 32 billion by 2030, according to a new research study by Future Market Insights (FMI). This growth trajectory is highlighted in the report titled “Global Cancer Supportive Care Products Industry,” offering valuable insights for stakeholders looking to navigate this dynamic market.

Booming Market Attracts New Players:

The significant unmet needs and promising growth potential are attracting a surge of new players to the cancer-supportive care products market. This trend is evident in the oncology drug development pipeline, where the percentage of compounds in preclinical stages has risen significantly. In 2000, only 23% of preclinical drugs targeted oncological applications. This figure skyrocketed to 38% by 2019, reflecting the increased focus on developing novel supportive care solutions for cancer patients.

This is increasing the market competition about clinical-trial recruitment – for instance, the number of breast cancer patients needed for active clinical trials is surpassing the yearly figure of diagnoses.

Efforts to manage drug expenditure have channeled the focus towards cancer-supportive care products, especially in developed regions, where value-based health-technology assessments (HTAs) are prevalent.

The Global Cancer Supportive Care Products Industry is characterized by a rapidly growing and globalized standard of medical care. Case in point, in non-small-cell lung cancer, the number of approved therapies was estimated to rise from 14 in 2009 to 22 by 2019.

This, coupled with limited data during accelerated approvals, implies that manufacturers are working in close collaboration with payers to create a value proposition for cancer-supportive care products.

Key Takeaways of Global Cancer Supportive Care Products Industry Study

Incidences of cancer have surged by around 26% among geriatric demographics compared to 10% among the remaining population
Adoption of cancer supportive care products to remain prominent in treating lung cancer
Pharma companies to invest 30% of their spending in cancer R&D to launch novel drugs and therapies in the marketplace
Market in Asia Pacific (APAC) to experience meteoric growth through 2030

COVID-19 Impact on Global Cancer Supportive Care Products Industry

The COVID-19 pandemic has touched every facet of human life including, healthcare delivery for chronic disorders.

As such, these patients are highly susceptible to getting infected by COVID-19 due to their compromised immunity, putting cancer specialists and patients in a dilemma.

Several healthcare facilities are deferring “elective” screenings, surgeries, and other methods that are considered not urgent or not immediately fatal.

Such important decisions are taken on a case-to-case basis to make sure patients diagnosed with cancer are protected from contracting the coronavirus as well as to ensure that healthcare facilities are equipped with the resources necessary to treat cancer patients who are affected by the virus.

The COVID-19 crisis has disturbed the treatment pathways and in-progress care, thus, resulting in a temporary drop in demand for cancer-supportive care products.

“To address the untapped sections of society, several regulatory bodies are showing immediacy in granting approvals to certain cancer-supportive care products. Case in point, the US Food and Drug Administration (FDA) has approved Pfizer’s Nyvepria to help prevent infections in patients undergoing myelosuppressive chemotherapy,” says the analyst at FMI.

Global Cancer Supportive Care Products Industry – Competitive Intelligence

The Global Cancer Supportive Care Products Industry is highly competitive, with the presence of several small- and medium-sized players. Manufacturers are leveraging innovation into their best practices to have proper capabilities in place and stay ahead in the fast-growing and competitive arena.

Baxter International Inc. develops products under the business categories of renal Care, Medication Delivery, and Pharmaceuticals. The company develops REGLAN Injection, which is a metoclopramide injection.
Amgen Inc. makes and provides innovative human therapeutics – Neulasta, which is a PEGylated form of human granulocyte CSF.

Key Segment

Drug Class

Nonsteroidal Anti- Inflammatory Drugs
Anti-Infective
Anti-Emetics
Monoclonal Antibodies
Erythropoietin Stimulating Agents
Opioid Analgesics
Bisphosphonates
Granulocyte Colony Stimulating Factor

Indication

Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Ovarian Cancer
Melanoma
Others

Distribution Channel

Hospitals Pharmacies
Retail Pharmacies
Compounding Pharmacies

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us: